carbazochrome has been researched along with Bright Disease in 1 studies
carbazochrome: a hemostatic which increases capillary resistance & activates platelet factors, Note: Adona is a multimeaning tradename
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yagame, M | 1 |
| Tomino, Y | 1 |
| Miura, M | 1 |
| Suga, T | 1 |
| Endoh, M | 1 |
| Nomoto, Y | 1 |
| Sakai, H | 1 |
1 other study available for carbazochrome and Bright Disease
| Article | Year |
|---|---|
Clinical effect of dipyridamole in patients with IgA nephropathy.
Topics: Adrenochrome; Dipyridamole; Glomerulonephritis; Glomerulonephritis, IGA; Hematuria; Humans; Proteinu | 1986 |